A-MARK PRECIOUS METALS INC (AMRK)

US00181T1079 - Common Stock

40.34  -0.82 (-1.99%)

After market: 35.25 -5.09 (-12.62%)

Fundamental Rating

5

Overall AMRK gets a fundamental rating of 5 out of 10. We evaluated AMRK against 102 industry peers in the Financial Services industry. AMRK has only an average score on both its financial health and profitability. AMRK has a decent growth rate and is not valued too expensively.



6

1. Profitability

1.1 Basic Checks

AMRK had positive earnings in the past year.
AMRK had a negative operating cash flow in the past year.
Each year in the past 5 years AMRK has been profitable.
AMRK had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 6.79%, AMRK belongs to the top of the industry, outperforming 84.31% of the companies in the same industry.
The Return On Equity of AMRK (18.89%) is better than 84.31% of its industry peers.
AMRK has a Return On Invested Capital of 8.09%. This is amongst the best in the industry. AMRK outperforms 80.39% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AMRK is above the industry average of 8.07%.
Industry RankSector Rank
ROA 6.79%
ROE 18.89%
ROIC 8.09%
ROA(3y)10.9%
ROA(5y)7.41%
ROE(3y)32.41%
ROE(5y)26.12%
ROIC(3y)12.07%
ROIC(5y)8.23%

1.3 Margins

Looking at the Profit Margin, with a value of 1.10%, AMRK is doing worse than 62.75% of the companies in the same industry.
AMRK's Profit Margin has improved in the last couple of years.
AMRK's Operating Margin of 1.49% is on the low side compared to the rest of the industry. AMRK is outperformed by 67.65% of its industry peers.
In the last couple of years the Operating Margin of AMRK has grown nicely.
AMRK's Gross Margin of 2.50% is on the low side compared to the rest of the industry. AMRK is outperformed by 62.75% of its industry peers.
In the last couple of years the Gross Margin of AMRK has grown nicely.
Industry RankSector Rank
OM 1.49%
PM (TTM) 1.1%
GM 2.5%
OM growth 3Y48.98%
OM growth 5YN/A
PM growth 3Y44.47%
PM growth 5YN/A
GM growth 3Y37.27%
GM growth 5Y52.36%

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AMRK is creating some value.
Compared to 1 year ago, AMRK has less shares outstanding
The number of shares outstanding for AMRK has been increased compared to 5 years ago.
AMRK has a better debt/assets ratio than last year.

2.2 Solvency

AMRK has an Altman-Z score of 7.84. This indicates that AMRK is financially healthy and has little risk of bankruptcy at the moment.
AMRK has a Altman-Z score of 7.84. This is amongst the best in the industry. AMRK outperforms 93.14% of its industry peers.
A Debt/Equity ratio of 1.44 is on the high side and indicates that AMRK has dependencies on debt financing.
AMRK has a Debt to Equity ratio of 1.44. This is in the lower half of the industry: AMRK underperforms 64.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF N/A
Altman-Z 7.84
ROIC/WACC1.12
WACC7.25%

2.3 Liquidity

A Current Ratio of 1.86 indicates that AMRK should not have too much problems paying its short term obligations.
AMRK has a Current ratio of 1.86. This is in the better half of the industry: AMRK outperforms 75.49% of its industry peers.
AMRK has a Quick Ratio of 1.86. This is a bad value and indicates that AMRK is not financially healthy enough and could expect problems in meeting its short term obligations.
AMRK has a worse Quick ratio (0.32) than 73.53% of its industry peers.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 0.32

5

3. Growth

3.1 Past

The earnings per share for AMRK have decreased strongly by -27.61% in the last year.
AMRK shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 43.36% yearly.
AMRK shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.24%.
Measured over the past years, AMRK shows a small growth in Revenue. The Revenue has been growing by 4.07% on average per year.
EPS 1Y (TTM)-27.61%
EPS 3Y43.36%
EPS 5YN/A
EPS growth Q2Q-57.78%
Revenue 1Y (TTM)24.24%
Revenue growth 3Y19.36%
Revenue growth 5Y4.07%
Revenue growth Q2Q6.62%

3.2 Future

The Earnings Per Share is expected to decrease by -0.60% on average over the next years.
AMRK is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.79% yearly.
EPS Next Y-51.31%
EPS Next 2Y-9.1%
EPS Next 3Y-3.01%
EPS Next 5Y-0.6%
Revenue Next Year5.44%
Revenue Next 2Y9.24%
Revenue Next 3Y9.09%
Revenue Next 5Y8.79%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 8.94 indicates a reasonable valuation of AMRK.
Based on the Price/Earnings ratio, AMRK is valued cheaper than 80.39% of the companies in the same industry.
AMRK is valuated cheaply when we compare the Price/Earnings ratio to 28.11, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 7.69, the valuation of AMRK can be described as very cheap.
Based on the Price/Forward Earnings ratio, AMRK is valued cheaply inside the industry as 85.29% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of AMRK to the average of the S&P500 Index (20.39), we can say AMRK is valued rather cheaply.
Industry RankSector Rank
PE 8.94
Fwd PE 7.69

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AMRK is valued cheaper than 82.35% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.55

4.3 Compensation for Growth

AMRK has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as AMRK's earnings are expected to decrease with -3.01% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.1%
EPS Next 3Y-3.01%

5

5. Dividend

5.1 Amount

AMRK has a Yearly Dividend Yield of 1.93%. Purely for dividend investing, there may be better candidates out there.
AMRK's Dividend Yield is a higher than the industry average which is at 3.55.
Compared to an average S&P500 Dividend Yield of 2.40, AMRK has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.93%

5.2 History

The dividend of AMRK is nicely growing with an annual growth rate of 60.60%!
AMRK has been paying a dividend for over 5 years, so it has already some track record.
The dividend of AMRK decreased in the last 3 years.
Dividend Growth(5Y)60.6%
Div Incr Years2
Div Non Decr Years2

5.3 Sustainability

38.17% of the earnings are spent on dividend by AMRK. This is a low number and sustainable payout ratio.
DP38.17%
EPS Next 2Y-9.1%
EPS Next 3Y-3.01%

A-MARK PRECIOUS METALS INC

NASDAQ:AMRK (5/7/2024, 4:50:38 PM)

After market: 35.25 -5.09 (-12.62%)

40.34

-0.82 (-1.99%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap921.77M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 1.93%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 8.94
Fwd PE 7.69
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.79%
ROE 18.89%
ROCE
ROIC
ROICexc
ROICexgc
OM 1.49%
PM (TTM) 1.1%
GM 2.5%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover6.16
Health
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.86
Quick Ratio 0.32
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-27.61%
EPS 3Y43.36%
EPS 5Y
EPS growth Q2Q
EPS Next Y-51.31%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)24.24%
Revenue growth 3Y19.36%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y